Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Joseph Melenhorst

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Blood|October 24, 2002
Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesisFrank El Ouriaghli, Hiroshi Fujiwara, J Joseph Melenhorst, et al.
British Journal of Haematology|September 6, 2003
Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerismErkut Bahceci, Diane Epperson, Daniel C Douek, et al.
Frontiers of Medicine|December 18, 2021
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignanciesJian-Qing Mi, Jie Xu, Jianfeng Zhou, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 15, 2003
T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57J Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, et al.
Clinical and Experimental Medicine|April 26, 2020
Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancerStefan Lundh, In-Young Jung, Alexander Dimitri, et al.
Nature Cancer|February 5, 2022
Author Correction: Engineering-enhanced CAR T cells for improved cancer therapyMichael C Milone, Jie Xu, Sai-Juan Chen, et al.
Nature Cancer|September 6, 2021
Engineering enhanced CAR T-cells for improved cancer therapyMichael C Milone, Jie Xu, Sai-Juan Chen, et al.
Seminars in Cancer Biology|December 24, 2019
Mechanisms of resistance to CAR T cell therapiesNathan Singh, Elena Orlando, Jun Xu, et al.
Cytotherapy|November 2, 2013
Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cellsKazushi Tanimoto, Pawel Muranski, Samantha Miner, et al.
Blood|December 30, 2016
PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CARElise A Chong, J Joseph Melenhorst, Simon F Lacey, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Blood|October 24, 2002
Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesisFrank El Ouriaghli, Hiroshi Fujiwara, J Joseph Melenhorst, et al.
British Journal of Haematology|September 6, 2003
Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerismErkut Bahceci, Diane Epperson, Daniel C Douek, et al.
Frontiers of Medicine|December 18, 2021
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignanciesJian-Qing Mi, Jie Xu, Jianfeng Zhou, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 15, 2003
T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57J Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, et al.
Clinical and Experimental Medicine|April 26, 2020
Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancerStefan Lundh, In-Young Jung, Alexander Dimitri, et al.
Nature Cancer|February 5, 2022
Author Correction: Engineering-enhanced CAR T cells for improved cancer therapyMichael C Milone, Jie Xu, Sai-Juan Chen, et al.
Nature Cancer|September 6, 2021
Engineering enhanced CAR T-cells for improved cancer therapyMichael C Milone, Jie Xu, Sai-Juan Chen, et al.
Seminars in Cancer Biology|December 24, 2019
Mechanisms of resistance to CAR T cell therapiesNathan Singh, Elena Orlando, Jun Xu, et al.
Cytotherapy|November 2, 2013
Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cellsKazushi Tanimoto, Pawel Muranski, Samantha Miner, et al.
Blood|December 30, 2016
PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CARElise A Chong, J Joseph Melenhorst, Simon F Lacey, et al.
Pageof 10